Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro
出版年份 2022 全文链接
标题
Obatoclax inhibits SARS-CoV-2 entry by altered endosomal acidification and impaired cathepsin and furin activity in vitro
作者
关键词
-
出版物
Emerging Microbes & Infections
Volume 11, Issue 1, Pages 483-497
出版商
Informa UK Limited
发表日期
2022-01-06
DOI
10.1080/22221751.2022.2026739
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion
- (2021) Guido Papa et al. PLoS Pathogens
- The interplay between emerging human coronavirus infections and autophagy
- (2021) Zhenyu Zhao et al. Emerging Microbes & Infections
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
- (2021) Rita E. Chen et al. NATURE MEDICINE
- Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro
- (2021) Finny Varghese et al. Viruses-Basel
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes
- (2021) Yabin Zhang et al. Cell Discovery
- Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
- (2021) Mark S Graham et al. Lancet Public Health
- Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
- (2021) Emma C Wall et al. LANCET
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV
- (2020) Jia Liu et al. JOURNAL OF MEDICAL VIROLOGY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
- (2020) Markus Hoffmann et al. MOLECULAR CELL
- Author Correction: A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells
- (2020) Shutoku Matsuyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activity
- (2020) Gretchen Ehrenkaufer et al. PLoS Neglected Tropical Diseases
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes
- (2020) Ruochen Zang et al. Science Immunology
- Coronavirus membrane fusion mechanism offers a potential target for antiviral development
- (2020) Tiffany Tang et al. ANTIVIRAL RESEARCH
- Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
- (2020) Markus Hoffmann et al. NATURE
- Potential Antiviral Options against SARS-CoV-2 Infection
- (2020) Aleksandr Ianevski et al. Viruses-Basel
- TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells
- (2020) Dorothea Bestle et al. Life Science Alliance
- Molecular Architecture of the SARS-CoV-2 Virus
- (2020) Hangping Yao et al. CELL
- The UCSC SARS-CoV-2 Genome Browser
- (2020) Jason D. Fernandes et al. NATURE GENETICS
- Furin Inhibitors Block SARS-CoV-2 Spike Protein Cleavage to Suppress Virus Production and Cytopathic Effects
- (2020) Ya-Wen Cheng et al. Cell Reports
- Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status
- (2020) Narasimha M. Beeraka et al. Frontiers in Immunology
- Progress and Pitfalls in the Quest for Effective SARS-CoV-2 (COVID-19) Vaccines
- (2020) Katie L. Flanagan et al. Frontiers in Immunology
- A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds
- (2020) Lara Schöler et al. Frontiers in Immunology
- Furin: A Potential Therapeutic Target for COVID-19
- (2020) Canrong Wu et al. iScience
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Targeting TMPRSS2 and Cathepsin B/L together may be synergistic against SARS-CoV-2 infection
- (2020) Pranesh Padmanabhan et al. PLoS Computational Biology
- Glucosamine promotes hepatitis B virus replication through its dual effects in suppressing autophagic degradation and inhibiting MTORC1 signaling
- (2019) Yong Lin et al. Autophagy
- Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine
- (2019) Andersen et al. Viruses-Basel
- Classics in Chemical Neuroscience: Chlorpromazine
- (2018) Debra Boyd-Kimball et al. ACS Chemical Neuroscience
- The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR
- (2018) Jo-Chi Kao et al. PLoS Neglected Tropical Diseases
- Infectious bronchitis virus entry mainly depends on clathrin mediated endocytosis and requires classical endosomal/lysosomal system
- (2018) Huan Wang et al. VIROLOGY
- Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic Environment of Endocytic Compartments
- (2016) Finny S. Varghese et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ATP1A1-Mediated Src Signaling Inhibits Coronavirus Entry into Host Cells
- (2015) Christine Burkard et al. JOURNAL OF VIROLOGY
- Obatoclax in combination with fludarabine and rituximab is well-tolerated and shows promising clinical activity in relapsed chronic lymphocytic leukemia
- (2015) Jennifer R. Brown et al. LEUKEMIA & LYMPHOMA
- Host cell proteases: Critical determinants of coronavirus tropism and pathogenesis
- (2015) Jean Kaoru Millet et al. VIRUS RESEARCH
- Coronavirus Cell Entry Occurs through the Endo-/Lysosomal Pathway in a Proteolysis-Dependent Manner
- (2014) Christine Burkard et al. PLoS Pathogens
- Suppression of Lysosome Function Induces Autophagy via a Feedback Down-regulation of MTOR Complex 1 (MTORC1) Activity
- (2013) Min Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Obatoclax Mesylate, a Pan–Bcl-2 Inhibitor, in Combination with Docetaxel in a Phase 1/2 Trial in Relapsed Non–Small-Cell Lung Cancer
- (2013) Alberto Chiappori et al. Journal of Thoracic Oncology
- A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
- (2012) Carmine Settembre et al. EMBO JOURNAL
- Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Influenza A Virus Infection
- (2012) Oxana V. Denisova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the B-Cell Lymphoma/Leukemia 2 Family in Cancer
- (2012) Matthew S. Davids et al. JOURNAL OF CLINICAL ONCOLOGY
- Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry
- (2012) M. Kawase et al. JOURNAL OF VIROLOGY
- Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence
- (2012) Taylor Heald-Sargent et al. Viruses-Basel
- A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry
- (2010) A. Shulla et al. JOURNAL OF VIROLOGY
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
- (2010) S. Matsuyama et al. JOURNAL OF VIROLOGY
- Obatoclax induces Atg7-dependent autophagy independent of beclin-1 and BAX/BAK
- (2010) F McCoy et al. Cell Death & Disease
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started